A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients

NCT01253278 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2393910
DRUG: Placebo

Sponsor

Eli Lilly and Company